Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania

BACKGROUND: Dihydroartemisinin-piperaquine (DhP) is highly recommended for the treatment of uncomplicated malaria. This study aims to compare the costs, health benefits and cost-effectiveness of DhP and artemether-lumefantrine (AL) alongside “do-nothing” as a baseline comparator in order to consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Amani T, Ngalesoni, Frida, Norheim, Ole F, Robberstad, Bjarne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171550/
https://www.ncbi.nlm.nih.gov/pubmed/25223864
http://dx.doi.org/10.1186/1475-2875-13-363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171550/
https://www.ncbi.nlm.nih.gov/pubmed/25223864
http://dx.doi.org/10.1186/1475-2875-13-363

Ejemplares similares